Oxcarbazepine for Suspension(Zhejiang Poly Pharma)

奥卡西平干混悬剂(浙江普利药业)

Report date: 2025/08/15 10:47:53

Base Information

Drug NameOxcarbazepine for Suspension(Zhejiang Poly Pharma)
Drug Alias NameOxcarbazepinum氧卡巴氮平Oxcarbazepina奥卡西平干混悬剂(2.2类改良型)Oxacarbazepine
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium channel alpha subunit blockers
TargetsSodium channel alpha subunit
Therapy Area/IndicationsSeizuresEpilepsy, Tonic-ClonicEpilepsies, Partial
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsSeizuresEpilepsy, Tonic-ClonicEpilepsies, Partial
Inactive IndicationsN/A

Other Information

ATC CodeN/A